Perkins Capital Management’s BioLife Solutions BLFS Stock Holding History

Perkins Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Hold	12,500	–	–	0.22%	71
2025 Q4	$302K	Hold	12,500	–	–	0.24%	72
2025 Q3	$319K	Hold	12,500	–	–	0.28%	66
2025 Q2	$269K	Sell	12,500 -1,000	-7%	-$22.5K	0.27%	63
2025 Q1	$308K	Hold	13,500	–	–	0.33%	64
2024 Q4	$350K	Hold	13,500	–	–	0.31%	63
2024 Q3	$338K	Hold	13,500	–	–	0.32%	64
2024 Q2	$289K	Hold	13,500	–	–	0.27%	71
2024 Q1	$250K	Sell	13,500 -17,500	-56%	-$306K	0.21%	76
2023 Q4	$504K	Hold	31,000	–	–	0.43%	63
2023 Q3	$428K	Hold	31,000	–	–	0.42%	64
2023 Q2	$685K	Sell	31,000 -1,000	-3%	-$21.1K	0.6%	49
2023 Q1	$696K	Hold	32,000	–	–	0.66%	49
2022 Q4	$582K	Hold	32,000	–	–	0.61%	47
2022 Q3	$728K	Hold	32,000	–	–	0.81%	38
2022 Q2	$442K	Buy	32,000 +11,000	+52%	+$161K	0.46%	62
2022 Q1	$477K	Hold	21,000	–	–	0.39%	68
2021 Q4	$783K	Hold	21,000	–	–	0.53%	60
2021 Q3	$889K	Sell	21,000 -1,000	-5%	-$48.2K	0.55%	54
2021 Q2	$979K	Sell	22,000 -500	-2%	-$17.6K	0.56%	54
2021 Q1	$810K	Sell	22,500 -14,500	-39%	-$573K	0.47%	59
2020 Q4	$1.48M	Sell	37,000 -26,650	-42%	-$909K	0.97%	37
2020 Q3	$1.84M	Buy	+63,650	New	+$1.37M	1.69%	18
2020 Q1	$610K	Sell	64,250 -17,300	-21%	-$238K	0.74%	48
2019 Q4	$1.32M	Sell	81,550 -29,700	-27%	-$483K	1.18%	27
2019 Q3	$1.85M	Buy	111,250 +58,500	+111%	+$1.1M	1.59%	19
2019 Q2	$894K	Sell	52,750 -8,000	-13%	-$139K	0.63%	47
2019 Q1	$1.09M	Buy	60,750 +10,000	+20%	+$159K	0.72%	44
2018 Q4	$611K	Sell	50,750 -88,400	-64%	-$1.06M	0.47%	65
2018 Q3	$2.44M	Sell	139,150 -18,650	-12%	-$369K	1.46%	19
2018 Q2	$1.8M	Buy	157,800 +130,300	+474%	+$1.19M	1.29%	20
2018 Q1	$141K	Buy	27,500 +16,500	+150%	+$89.3K	0.13%	105
2017 Q4	$66K	Sell	11,000 -4,000	-27%	-$23.1K	0.06%	104
2017 Q3	$86K	Buy	15,000 +5,000	+50%	+$20.7K	0.09%	94
2017 Q2	$24K	Hold	10,000	–	–	0.03%	106
2017 Q1	$21K	Hold	10,000	–	–	0.02%	111
2016 Q4	$16K	Hold	10,000	–	–	0.02%	103
2016 Q3	$18K	Hold	10,000	–	–	0.02%	110
2016 Q2	$16K	Hold	10,000	–	–	0.02%	113
2016 Q1	$18K	Hold	10,000	–	–	0.02%	111
2015 Q4	$22K	Hold	10,000	–	–	0.02%	118
2015 Q3	$21K	Hold	10,000	–	–	0.02%	120
2015 Q2	$20K	Hold	10,000	–	–	0.02%	128
2015 Q1	$16K	Hold	10,000	–	–	0.01%	134
2014 Q4	$16K	Sell	10,000 -9,372	-48%	-$19.3K	0.01%	128
2014 Q3	$41K	Sell	19,372 -116,628	-86%	-$278K	0.03%	137
2014 Q2	$310K	Buy	+136,000	New	+$367K	0.22%	100

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Perkins Capital Management's BLFS Position: Q1 2026 in Review

Perkins Capital Management held its BioLife Solutions (BLFS) position steady in Q1 2026 at 12,500 shares worth $239K. The position accounts for 0.22% of the portfolio, ranked #71.

Perkins Capital Management first reported a position in BLFS in Q2 2014 and has held it in 47 quarters since. The position peaked at $2.44M in Q3 2018. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

Perkins Capital Management held 12,500 shares of BioLife Solutions worth $239K as of Q1 2026.
Perkins Capital Management left its BioLife Solutions share count unchanged in Q1 2026.
BioLife Solutions made up 0.22% of Perkins Capital Management's portfolio in Q1 2026, its #71 holding.
Perkins Capital Management first reported a position in BioLife Solutions in Q2 2014 and has held it in 47 quarters since.
Perkins Capital Management's BioLife Solutions position peaked at $2.44M in Q3 2018.
187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Perkins Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.